Abiopharma

📋 MATT EHRLICHMAN (Officer) plans to sell 97K shares of Porch Group, Inc. (at $7.32 each, total $713K) Filed: Apr 02, 2026 | ID: 000006

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001918704-26-009105 <b>Size:</b> 997 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001839882-26-018819 <b>Size:</b> 1 MB

(80% Positive) CONTEXT THERAPEUTICS INC. (CNTX) Provides Update on expected for solid tumors

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001918704-26-009104 <b>Size:</b> 567 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001918704-26-009103 <b>Size:</b> 915 KB

BLUE MOON METALS INC. (BMM) Files Form 6-K

General Announcement: Overseas Regulatory Announcement

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001918704-26-009102 <b>Size:</b> 974 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001213900-26-038960 <b>Size:</b> 2 MB

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001839882-26-018816 <b>Size:</b> 552 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001918704-26-009101 <b>Size:</b> 1 MB

GSK PLC (GSK) Files Form 6-K

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Changes in Interest of Director and Chief Executive Officer - Dr. Ng Chin Siau

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Changes in Interest of Substantial Shareholder - Quan Min Holdings Pte. Ltd.